Who owns SAREPTA THERAPEUTICS INC NOTE 1.250 9/1?
- CUSIP Number: 803607ad2
Tip: Access positions for across all investors
Analyze quarterly positions in Sarepta Therapeutics Inc Note 1.250 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sarepta Therapeutics Inc Note 1.250 9/1 stock
Who bought or sold SAREPTA THERAPEUTICS INC NOTE 1.250 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jpmorgan Chase & Co | 57M | $55M | 100% | Mar 2026 |
|
| Highbridge Capital Management | 57M | $52M | 55% | Dec 2025 |
|
| DG Capital Management | 22M | $21M | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 17M | $16M | 0% | Mar 2026 |
|
| LMR Partners | 16M | $15M | 10% | Mar 2026 |
|
| Calamos Advisors | 15M | $14M | 0% | Mar 2026 |
|
| Corbyn Investment Management | 11M | $10M | 100% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 3.5M | $3.1M | -20% | Dec 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $2.7M | 0% | Dec 2025 |
|
| Palisade Capital Management | 1.7M | $1.6M | -47% | Dec 2025 |
|
| FMR | 1.5M | $1.3M | -69% | Dec 2025 |
|
| Advent Capital Management | 1.0M | $922k | -90% | Mar 2026 |
|
| Financial Consulate | 999k | $920k | 100% | Mar 2026 |
|
| Morgan Stanley | 810k | $744k | 100% | Mar 2026 |
|
| HB Wealth Management | 555k | $511k | 100% | Mar 2026 |
|
| Leucadia National Corporation | 90k | $83k | 100% | Mar 2026 |
|
| Branch Banking & Trust Company | 71k | $65k | 0% | Mar 2026 |
|
| Capital Investment Advisory Services | 37k | $34k | 0% | Mar 2026 |
|
| Sontag Advisory | 27k | $25k | 100% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 13k | $12k | 100% | Mar 2026 |
|
| Rothschild Investment | 1.0k | $919.000000 | 0% | Mar 2026 |
|
| UBS Group | 500.00 | $460.000000 | 0% | Mar 2026 |
|
| Alken Asset Management | 400.00 | $366k | 0% | Mar 2026 |
|
Who sold out of Sarepta Therapeutics Inc Note 1.250 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2025 | 41M | $36M |
| Oaktree Capital Management | Sep 2025 | 35M | $31M |
| State Street Corporation | Sep 2025 | 9.2M | $8.1M |
| Exome Asset Management | Sep 2025 | 2.0M | $1.8M |
| Toronto-Dominion Bank | Sep 2025 | 1.1M | $945k |
| New York State Common Retirement Fund | Dec 2025 | 953k | $848k |